Your journey, our Science

Changes in the composition and activity of the gut microbiota - often referred to as dysbiosis - have been studied in relation to intestinal barrier function and immune responses. Scientific literature suggests that certain microbial patterns may coincide with increased intestinal permeability and immune activation, which are observed in individuals with metabolic conditions.

The microbiota can influence how our body interacts with food. Research indicates that microbial composition may affect how energy is extracted from food and how certain signaling molecules influence appetite or gut-brain communication. These dynamics are part of a larger system that supports nutritional balance.

SCFAs such as butyrate, acetate, and propionate are produced by the fermentation of fiber by gut bacteria. They have been studied for their potential roles in supporting intestinal cell nutrition, gut barrier function, and immune regulation. These natural bacterial by-products are an exciting area of research in gut and metabolic science.

Some lactic acid bacteria have been studied for their potential to support the integrity of the intestinal barrier and contribute to the balance of the microbiome. Although further research is needed, preliminary evidence suggests that certain strains may play a complementary role in modulating the microbiome in adults with dietary or lifestyle changes.

Its complexity and adaptability. It responds to diet, age, environment — and holds promise for preventive health strategies. There’s still much to learn about how we can support it through lifestyle, nutrition, and supplementation.

We began by reviewing areas where digestive balance is often challenged - for instance, during significant dietary shifts or structured weight management. We selected bacterial strains that have been studied for their role in microbiome resilience and GI comfort, particularly in adults undergoing metabolic interventions.

A high CFU (colony-forming units) count is important to ensure that enough live bacteria reach the gut. Forte80™ delivers 80 billion CFU per day using advanced capsule technology designed to protect the viability of the strains during digestion.

We conducted a meta-analysis of over 250 scientific studies, supported by AI-based literature mapping, to identify strains that have been studied in relation to microbiome balance and digestive adaptation. These were selected for their quality, stability, and relevance to adult gut health.

People who use GLP-1-based therapies often report changes in digestion and appetite.

The gut is incredibly dynamic - it’s not just about digestion, but about how we adapt to life changes. I see the microbiome as a key part of the future of personalized nutrition and wellness.

Many people who are concerned about their weight report changes in their digestive system. Supporting the intestinal flora is therefore essential.

We’re seeing a shift from simply managing outcomes to supporting overall biological balance. Microbiome science offers a complementary lens - not to replace medications, but to support overall well-being in an increasingly personalized healthcare landscape.

I believe targeted microbiome support will become a core part of holistic care - not as a stand-alone, but as a supportive element alongside nutritional strategies, exercise, and advanced therapies like GLP-1s. The future is personalized, and the microbiome is part of that equation.

Because the microbiome is often misunderstood. People deserve clear, science-based information - not hype. At Azento Health, we aim to provide clarity, backed by scientific integrity.

We’re at the beginning of a new chapter in health. For me, it’s not just about selling a product - it’s about giving people tools that are grounded in science and respectful of their journey.